Table 3.

Multivariate Cox regression analysis of factors associated with overall survival

Multivariate survival (N = 128 patients)	Comparison	Hazard ratio (95% CI)	P
Ascites at baseline	No ascites	2.21 (1.10, 4.47)	0.027
Albumin	Unit = 1 g/dl	0.37 (0.22, 0.64)	<0.001
BCLC Stage C or D	BCLC Stage B	4.11 (2.11, 8.01)	<0.001
Largest lesion size > 5 cm (including diffuse)	Largest lesion Size < 5 cm	2.48 (1.31, 4.67)	0.005
TACE/DEB	Y90 alone	0.66 (0.37, 1.17)	0.115
Y90 and TACE/DEB	Y90 alone	1.09 (0.44, 2.66)	0.859
Number of treatments	Unit = 1 treatment	0.73 (0.52, 1.04)	0.079
Progressive disease	Complete Response	7.62 (2.21, 26.3)	<0.001
Stable disease	Complete Response	5.33 (1.42, 20.0)	0.013
Partial response	Complete Response	3.66 (1.01, 13.3)	0.048

The bold text indicates a significant value.

BCLC, Barcelona Clinic Liver Cancer; TACE/DEB, transarterial chemotherapy with drug-eluting beads.